Skip to content
About
Services
Resources
Contact
Open Search
Search
About
Services
Resources
Contact
Open Search
Close Menu
Scientific Paper
Scientific Paper
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers
April 27, 2023
Scientific Paper
Temporal, spatial and molecular pattern of dopaminergic neurodegeneration in the AAV-A53T α-synuclein rat model of Parkinson’s disease
April 27, 2023
Scientific Paper
Toward in vivo proof of binding of 18F-labeled inhibitor to peripheral tropomyosin receptor kinases
April 27, 2023
Scientific Paper
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
April 27, 2023
Scientific Paper
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
April 27, 2023
Scientific Paper
a-Synuclein-induced Kv4
April 27, 2023
Scientific Paper
Exosome markers of LRRK2 kinase inhibition
April 27, 2023
Scientific Paper
A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance…
April 27, 2023
Scientific Paper
The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques
April 27, 2023
Scientific Paper
Early-onset impairment of the ubiquitinproteasome system in dopaminergic neurons caused by α-synuclein
April 27, 2023
Posts navigation
1
2
…
7
Next
At Atuka, we combine our capabilities with yours to harness the power of partnership and advance your therapeutic program.
Talk to a Neuroscience Expert
Scroll Up